Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Perrigo Company has filed an abbreviated new drug application for Fluocinonide cream 0.1%, a generic version of Vanos cream 0.1%.
Subscribe to our email newsletter
The company believes that it is the first to file an abbreviated new drug application (ANDA) with a Paragraph IV certification against Vanos.
Perrigo filed its ANDA for Fluocinonide cream, 0.1% containing a Paragraph IV Certification with the FDA and notified Medicis Pharmaceutical, the listed patent holder of its filing.
Vanos (fluocinonide) cream 0.1% is a corticosteroid (steroid hormone) approved to relieve the inflammation and itching caused by certain skin conditions that respond to treatment with corticosteroids in patients 12 years of age or older.